ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
LeonaBio Inc

LeonaBio Inc (LONA)

8,4293
0,1993
( 2,42% )
Aktualisiert: 17:24:06

LeonaBio Inc (LONA) Aktie

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
8,4293
( 2,42% )
Gebot
8,09
Fragen
8,45
Volumen
1.080
8,0745 Tagesbereich 8,46
4,20 52-Wochen-Bereich 14,21
Marktkapitalisierung
Handelsende
8,23
Handelsbeginn
8,32
Letzte Trade
10
@
8.42
Letzter Handelszeitpunkt
17:24:12
Finanzvolumen
US$ 9.004
VWAP
8,3369
Durchschnittliches Volumen (3 Mio.)
US$ 62.363
Ausgegebene Aktien
9.393.514
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-0,61
Gewinn pro Aktie (EPS)
-16,06
Erlöse (LTM)
-
Nettogewinn (LTM)
-129,41M

Über LeonaBio Inc

LeonaBio, Inc., clinical-stage biopharmaceutical company, engages in the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis. The company’s lead products include lasofoxifene and ATH-1105, a novel sm... LeonaBio, Inc., clinical-stage biopharmaceutical company, engages in the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis. The company’s lead products include lasofoxifene and ATH-1105, a novel small molecule therapies with the potential to address devastating diseases where current treatment options are limited or ineffective. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is in phase 1 clinical trial; ATH-1020 for the treatment of diabetic neuropathy, which is in phase 1 clinical trial; and ATH-1017 for the treatment of Alzheimer’s disease and Parkinson’s disease, which is in phase 2 clinical trial, as well as early compounds which is in preclinical phase. The company was formerly known as Athira Pharma, Inc. and changed its name to LeonaBio, Inc. in January 2026. LeonaBio, Inc. was incorporated in 2011 and is headquartered in Bothell, Washington. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Hauptsitz
Bothell, United States
Gegründet
2026
LeonaBio Inc is listed in the Healthcare sector of the NASDAQ with ticker LONA. The last closing price for LeonaBio was US$8,23. Over the last year, LeonaBio shares have traded in a share price range of US$ 4,20 to US$ 14,21.

LeonaBio currently has 9.393.514 shares in issue. The market capitalisation of LeonaBio is US$79,18 million. LeonaBio has a price to earnings ratio (PE ratio) of -0.61.

LONA Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.0707-0.8317647058828.59.367.8091146218.20131239CS
4-1.0307-10.89534883729.4611.447.8091317539.39319847CS
12-1.3607-13.89887640459.7912.477.76371979.60580378CS
261.879328.69160305346.5514.214.2513307.95762929CS
521.879328.69160305346.5514.214.2513307.95762929CS
1561.879328.69160305346.5514.214.2513307.95762929CS
2601.879328.69160305346.5514.214.2513307.95762929CS

LONA - Frequently Asked Questions (FAQ)

What is the current LeonaBio Inc share price?
The current share price of LeonaBio Inc is US$ 8,4293
How many LeonaBio Inc shares are in issue?
LeonaBio Inc has 9.393.514 shares in issue
What is the market cap of LeonaBio Inc?
The market capitalisation of LeonaBio Inc is USD 79,18M
What is the 1 year trading range for LeonaBio Inc share price?
LeonaBio Inc has traded in the range of US$ 4,20 to US$ 14,21 during the past year
What is the PE ratio of LeonaBio Inc?
The price to earnings ratio of LeonaBio Inc is -0,61
What is the registered address of LeonaBio Inc?
The registered address for LeonaBio Inc is 18706 North Creek Parkway, Bothell, Washington, 98011
What is the LeonaBio Inc website address?
The website address for LeonaBio Inc is www.leonabio.com
Which industry sector does LeonaBio Inc operate in?
LeonaBio Inc operates in the Biotechnology & Life Sciences sector

LONA Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen